Raidah Al-Baradie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raidah Al-Baradie has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Shahid Bashir
Neuroscience Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
3 shared publications - Aileen McGonigal
Epilepsy Unit, Mater Hospital, South Brisbane, 4101, Australia; Mater Research Institute, University of Queensland, South Brisbane, 4101, Australia; Queensland Brain Institute, University of Queensland, South Brisbane, 4067, Australia
2 shared publications - Akio Ikeda
Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
2 shared publications - Ali Mir
Department of Pediatric Neurology, Neuroscience Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
2 shared publications - Alicia Bogacz Fressola
Neurological Institute, Universidad de la República, Montevideo, Uruguay
2 shared publications - Angelica Lizcano
Epilepsy Surgery Program, Neurocentro, Calle 12 #18-24 Torre 3 Piso 3, Pereira 660003, Colombia
2 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Evaluating the pediatric neurology training curriculum in SCFHS-accredited programs: a multi-institutional survey study
Background: Pediatric neurology training must evolve to meet increasing clinical complexity and rapid advances in neuroscience while maintaining high standards of family-centered care. In Saudi Arabia, structured residency programs have expanded under national accreditation frameworks; however, systematic evaluations of curriculum adequacy from the faculty perspective remain limited. This study aimed to comprehensively evaluate the pediatric neurology training curriculum within the Saudi Commission for Health Specialties (SCFHS)-accredited training system (including programs in Saudi Arabia and the United Arab Emirates [UAE]) from the faculty perspective, identifying strengths, gaps, and differences between program directors (PDs) and non-director faculty. Methods: We conducted a multi-institutional cross-sectional study between September and December 2025 targeting pediatric neurology faculty, including PDs, deputy directors, core faculty, and clinical staff involved in resident education. A validated 47-item questionnaire assessed satisfaction across six core curriculum components (educational resources, graduate autonomy and safety, clinical knowledge, clinical–academic balance, research opportunities, and professionalism), identified priority training gaps, and collected qualitative recommendations. Quantitative data were analyzed using descriptive statistics, non-parametric comparisons, correlation analysis, and exploratory multivariable linear regression. Open-ended responses underwent inductive thematic analysis. Results: Forty-three consultants participated, including nine PDs. Overall satisfaction was moderate, with the highest ratings for resident professionalism (mean 3.8/5) and the lowest for clinical–academic balance (2.8/5) and research opportunities (2.9/5). Genetics and hereditary diseases (74%), neuroimmunology (70%), and neurodevelopmental disorders (63%) were the most frequently cited domains requiring greater emphasis. PDs reported significantly lower overall satisfaction than non-directors (β = −0.37, p = 0.02), particularly regarding academic time and research infrastructure. Satisfaction with educational resources strongly correlated with perceived research opportunities (ρ = 0.58, p < 0.001). Qualitative themes highlighted excessive service demands, insufficient protected academic time, limited research mentorship, and the need for structured training in rapidly evolving subspecialties. Conclusion: Pediatric neurology training in the region demonstrates strong clinical and professional foundations but is constrained by systemic challenges in academic balance, research support, and subspecialty preparedness. These perception-based findings suggest that PDs’ heightened concerns may inform future curriculum development. Potential areas for consideration include protected academic time, enhanced research infrastructure, and nationally coordinated curricula in high-priority domains. However, these are exploratory implications requiring further evaluation before implementation.
- 17 July 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessEvaluating the pediatric neurology training curriculum in SCFHS-accredited programs: a multi-institutional survey study
Background: Pediatric neurology training must evolve to meet increasing clinical complexity and rapid advances in neuroscience while maintaining high standards of family-centered care. In Saudi Arabia, structured residency programs have expanded under national accreditation frameworks; however, systematic evaluations of curriculum adequacy from the faculty perspective remain limited. This study aimed to comprehensively evaluate the pediatric neurology training curriculum within the Saudi Commission for Health Specialties (SCFHS)-accredited training system (including programs in Saudi Arabia and the United Arab Emirates [UAE]) from the faculty perspective, identifying strengths, gaps, and differences between program directors (PDs) and non-director faculty. Methods: We conducted a multi-institutional cross-sectional study between September and December 2025 targeting pediatric neurology faculty, including PDs, deputy directors, core faculty, and clinical staff involved in resident education. A validated 47-item questionnaire assessed satisfaction across six core curriculum components (educational resources, graduate autonomy and safety, clinical knowledge, clinical–academic balance, research opportunities, and professionalism), identified priority training gaps, and collected qualitative recommendations. Quantitative data were analyzed using descriptive statistics, non-parametric comparisons, correlation analysis, and exploratory multivariable linear regression. Open-ended responses underwent inductive thematic analysis. Results: Forty-three consultants participated, including nine PDs. Overall satisfaction was moderate, with the highest ratings for resident professionalism (mean 3.8/5) and the lowest for clinical–academic balance (2.8/5) and research opportunities (2.9/5). Genetics and hereditary diseases (74%), neuroimmunology (70%), and neurodevelopmental disorders (63%) were the most frequently cited domains requiring greater emphasis. PDs reported significantly lower overall satisfaction than non-directors (β = −0.37, p = 0.02), particularly regarding academic time and research infrastructure. Satisfaction with educational resources strongly correlated with perceived research opportunities (ρ = 0.58, p < 0.001). Qualitative themes highlighted excessive service demands, insufficient protected academic time, limited research mentorship, and the need for structured training in rapidly evolving subspecialties. Conclusion: Pediatric neurology training in the region demonstrates strong clinical and professional foundations but is constrained by systemic challenges in academic balance, research support, and subspecialty preparedness. These perception-based findings suggest that PDs’ heightened concerns may inform future curriculum development. Potential areas for consideration include protected academic time, enhanced research infrastructure, and nationally coordinated curricula in high-priority domains. However, these are exploratory implications requiring further evaluation before implementation.
- Open Access
- 30 April 2026
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 31 (2) , 133-139
Predicting Epileptic Seizures From EEG Signals Using Machine Learning
Objective: To develop a machine learning-based model for predicting epileptic seizures by analyzing electroencephalogram (EEG) signals and classifying the interictal and preictal phases. Methods: The EEG signals were analyzed in both the time and frequency domains using advanced feature extraction techniques. Three different machine learning approaches were employed, with special focus on long short-term memory (LSTM) networks. Features were extracted and classified to differentiate between seizure and non-seizure phases. The proposed models were evaluated using the publicly available CHB-MIT EEG dataset. The study was conducted between September 2022 and September 2024. Results: Among the tested models, the LSTM-based approach using the full-feature extraction pipeline achieved the highest prediction accuracy of 97.73%. This performance demonstrates strong potential for real-time seizure forecasting. Conclusion: Machine learning, particularly LSTM models, can accurately predict epileptic seizures by analyzing EEG signal patterns. These findings support the development of automated seizure prediction systems that could significantly improve the quality of life for epilepsy patients.
- 30 April 2026
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 31 (2) , 133-139
Open AccessPredicting Epileptic Seizures From EEG Signals Using Machine Learning
Objective: To develop a machine learning-based model for predicting epileptic seizures by analyzing electroencephalogram (EEG) signals and classifying the interictal and preictal phases. Methods: The EEG signals were analyzed in both the time and frequency domains using advanced feature extraction techniques. Three different machine learning approaches were employed, with special focus on long short-term memory (LSTM) networks. Features were extracted and classified to differentiate between seizure and non-seizure phases. The proposed models were evaluated using the publicly available CHB-MIT EEG dataset. The study was conducted between September 2022 and September 2024. Results: Among the tested models, the LSTM-based approach using the full-feature extraction pipeline achieved the highest prediction accuracy of 97.73%. This performance demonstrates strong potential for real-time seizure forecasting. Conclusion: Machine learning, particularly LSTM models, can accurately predict epileptic seizures by analyzing EEG signal patterns. These findings support the development of automated seizure prediction systems that could significantly improve the quality of life for epilepsy patients.
- Open Access
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Revidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- 10 October 2025
- Published by Springer Nature in Clinical Epileptology
- Vol. 38 (4) , 278-295
Open AccessRevidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie
Zusammenfassung: Die Internationale Liga gegen Epilepsie (ILAE) hat die operationale Klassifikation epileptischer Anfälle 2017 auf der Grundlage der damals entwickelten Rahmenbedingungen aktualisiert. In diese Überarbeitung wurden die publizierten Erfahrungen mit der Umsetzung der 2017er-Klassifikation einbezogen. Eine 37 Personen zählende Arbeitsgruppe wurde vom ILAE-Exekutivausschuss eingesetzt. Die internationalen Expertinnen und Experten aus allen ILAE-Regionen wandten ein modifiziertes Delphi-Verfahren an, bei dem für jeden Vorschlag ein Konsens von mehr als zwei Dritteln erforderlich war. Nach Veröffentlichung auf der ILAE-Homepage mit dem Ersuchen, Kommentare zu dem Entwurf einzugeben, ernannte der Exekutivausschuss 7 zusätzliche Sachverständige für die Arbeitsgruppe zur Überarbeitung des Positionspapieres, um die eingegangenen Kommentare zu diskutieren und gegebenenfalls einzubeziehen. Die aktualisierte Klassifikation behält die Hauptklassen von Anfällen bei: fokal, generalisiert, unbekannt (ob fokal oder generalisiert) und nicht klassifiziert. Taxonomische Regeln unterscheiden zwischen Klassifikatoren , die biologische Klassen widerspiegeln und sich direkt auf die klinische Behandlung auswirken, und Deskriptoren , die andere wichtige Anfallsmerkmale angeben. Fokale Anfälle und Anfälle unbekannten Ursprungs werden darüber hinaus nach dem Bewusstseinszustand des Patienten während des Anfalls klassifiziert, je nachdem ob eine Bewusstseinsstörung vorliegt oder nicht. Die Bewertung, ob eine Bewusstseinsstörung vorliegt, wird durch Gewahrsein (engl. „awareness“) und Reaktionsfähigkeit (engl. „responsiveness“) während eines Anfalls und erhaltene Erinnerung (engl. „recall“) nach einem Anfall klinisch operationalisiert. Wenn der Bewusstseinszustand nicht bestimmbar ist, wird der Anfall unter dem übergeordneten Begriff, d. h. der Hauptanfallsklasse (fokaler Anfall oder Anfall unbekannten Ursprungs) klassifiziert. Generalisierte Anfälle werden in Absencen, generalisierte tonisch-klonische Anfälle und andere generalisierte Anfälle eingeteilt, wobei jetzt auch der negative Myoklonus als Anfallstyp beschrieben wird. Anfälle werden in der Grundversion als solche mit oder ohne beobachtbare Manifestationen beschrieben, während eine erweiterte Version die chronologische Abfolge der Anfallssemiologie verwendet. Diese aktualisierte Klassifikation umfasst 4 Hauptklassen und nur noch 21 Anfallstypen (und nicht mehr 63 wie in der 2017 Klassifikation; Anm. d. Übersetzer). Besonderer Wert wurde auf die Übersetzbarkeit in andere Sprachen jenseits von Englisch gelegt. Ziel ist es, eine gemeinsame Sprache für alle im Bereich Epilepsie tätigen Gesundheitsfachkräfte zu schaffen – von ressourcenarmen Gebieten bis hin zu hoch spezialisierten Zentren – und leicht zugängliche Begriffe für Patientinnen und Patienten sowie Betreuungspersonen bereitzustellen.
- Top Cited PapersOpen Access
Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic–clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource‐limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
Top Cited PapersOpen AccessUpdated classification of epileptic seizures: Position paper of the International League Against Epilepsy
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework established in 2017. This revision, informed by the implementation experience, involved a working group appointed by the ILAE Executive Committee. Comprising 37 members from all ILAE regions, the group utilized a modified Delphi process, requiring a consensus threshold of more than two thirds for any proposal. Following public comments, the Executive Committee appointed seven additional experts to the revision task force to address and incorporate the issues raised, as appropriate. The updated classification maintains four main seizure classes: Focal, Generalized, Unknown (whether focal or generalized), and Unclassified. Taxonomic rules distinguish classifiers, which are considered to reflect biological classes and directly impact clinical management, from descriptors, which indicate other important seizure characteristics. Focal seizures and those of unknown origin are further classified by the patient's state of consciousness (impaired or preserved) during the seizure, defined operationally through clinical assessment of awareness and responsiveness. If the state of consciousness is undetermined, the seizure is classified under the parent term, that is, the main seizure class (focal seizure or seizure of unknown origin). Generalized seizures are grouped into absence seizures, generalized tonic–clonic seizures, and other generalized seizures, now including recognition of negative myoclonus as a seizure type. Seizures are described in the basic version as with or without observable manifestations, whereas an expanded version utilizes the chronological sequence of seizure semiology. This updated classification comprises four main classes and 21 seizure types. Special emphasis was placed on ensuring translatability into languages beyond English. Its aim is to establish a common language for all health care professionals involved in epilepsy care, from resource‐limited areas to highly specialized centers, and to provide accessible terms for patients and caregivers.
- Open Access
- 7 April 2025
- Published by Springer Nature in Acta Epileptologica
- Vol. 7 (1) , 1-6
The impact of hydrocephalus on pediatric epilepsy: insights from a single-center investigation
Background: Hydrocephalus following intracerebral hemorrhage (ICH) is a common yet treatable complication. Despite its clinical significance, the long-term outcomes and predictive factors associated with hydrocephalus are not well understood, especially in pediatric population with epilepsy. This study aims to investigate the impact of hydrocephalus on children with epilepsy in Saudi Arabia. Methods: This observational retrospective study was conducted at the pediatric neurology clinic of a tertiary care epilepsy center. Twenty-six patients diagnosed with comorbid hydrocephalus and epilepsy were included. Key variables analyzed included seizure characteristics, age at seizure onset, use of antiseizure medications, seizure control, long-term developmental outcomes (intellectual and motor), the timing of shunt insertion in relation to seizure onset, and focal EEG changes. Results: Among the 26 patients, 61.5% (n = 16) were males. A notable proportion, 57.7% (n = 15), exhibited normal electroencephalogram (EEG) results, while 42.3% (n = 11) presented with abnormal EEG patterns. Of the 26 patients, 38.4% (n = 10) had congenital hydrocephalus, while 61.6% (n = 16) had acquired hydrocephalus. Seizure frequency varied: 38.5% (n = 10) experienced only once seizure, 11.5% (n = 3) had one to four seizures per month and 3.8% (n = 1) encountered two to four seizures per day. The majority of hydrocephalus cases (61.5%, n = 16) were diagnosed during infancy to two years of age. Shunt insertion was prevalent, with 80.7% (n = 21) undergoing the procedure. Developmental delays were observed in 61.5% (n = 16) of the patients. Conclusions: This study highlights the important role of hydrocephalus in the context of epilepsy among children in Saudi Arabia. Further research with larger sample size is needed to confirm these findings and provide a basis for improved understanding and targeted interventions in this critical medical area.
- 7 April 2025
- Published by Springer Nature in Acta Epileptologica
- Vol. 7 (1) , 1-6
Open AccessThe impact of hydrocephalus on pediatric epilepsy: insights from a single-center investigation
Background: Hydrocephalus following intracerebral hemorrhage (ICH) is a common yet treatable complication. Despite its clinical significance, the long-term outcomes and predictive factors associated with hydrocephalus are not well understood, especially in pediatric population with epilepsy. This study aims to investigate the impact of hydrocephalus on children with epilepsy in Saudi Arabia. Methods: This observational retrospective study was conducted at the pediatric neurology clinic of a tertiary care epilepsy center. Twenty-six patients diagnosed with comorbid hydrocephalus and epilepsy were included. Key variables analyzed included seizure characteristics, age at seizure onset, use of antiseizure medications, seizure control, long-term developmental outcomes (intellectual and motor), the timing of shunt insertion in relation to seizure onset, and focal EEG changes. Results: Among the 26 patients, 61.5% (n = 16) were males. A notable proportion, 57.7% (n = 15), exhibited normal electroencephalogram (EEG) results, while 42.3% (n = 11) presented with abnormal EEG patterns. Of the 26 patients, 38.4% (n = 10) had congenital hydrocephalus, while 61.6% (n = 16) had acquired hydrocephalus. Seizure frequency varied: 38.5% (n = 10) experienced only once seizure, 11.5% (n = 3) had one to four seizures per month and 3.8% (n = 1) encountered two to four seizures per day. The majority of hydrocephalus cases (61.5%, n = 16) were diagnosed during infancy to two years of age. Shunt insertion was prevalent, with 80.7% (n = 21) undergoing the procedure. Developmental delays were observed in 61.5% (n = 16) of the patients. Conclusions: This study highlights the important role of hydrocephalus in the context of epilepsy among children in Saudi Arabia. Further research with larger sample size is needed to confirm these findings and provide a basis for improved understanding and targeted interventions in this critical medical area.
- Open Access
- 1 January 2025
- Published by King Salman Center for Disability Research in Journal of Disability Research
- Vol. 4 (6)
Repetitive Transcranial Magnetic Stimulation for Pediatric Epilepsy: Current Evidence, Challenges, and Future Directions
Drug-resistant epilepsy affects 20-30% of children, where early and effective intervention is critical for reducing seizure frequency and neurodevelopmental outcomes, yet it remains a major therapeutic challenge. Pharmacotherapy often fails, and surgery or vagus nerve stimulation is not universally feasible. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a non-invasive neuromodulation strategy that modulates cortical excitability with magnetic pulses. In pediatric populations, rTMS may not only reduce seizure frequency and electrographic abnormalities but also support developmental domains, with adverse effects typically being mild and transient (e.g., scalp discomfort, headache). Beyond seizure reduction, reports describe improvements in cognition, behavior, and quality of life that are particularly relevant for children’s learning and psychosocial development. Mechanistically, rTMS likely acts through two complementary pathways: (i) desynchronization of abnormal cortical oscillations and (ii) modulation of synaptic efficacy via long-term potentiation and long-term depression like plasticity. TMS also has diagnostic and presurgical uses via motor-evoked potentials, paired-pulse paradigms, and TMS-electroencephalography biomarkers, providing clinicians with tools that can inform individualized treatment planning in young patients. However, evidence is heterogeneous, reflecting differences in age, epilepsy subtype, and stimulation parameters, alongside small sample sizes and protocol variability. Concerns specific to pediatrics including the long-term neurodevelopmental safety of repeated stimulation during critical brain maturation remain insufficiently characterized. Practical barriers such as access, cost, and clinician familiarity further limit adoption. This review synthesizes current pediatric rTMS evidence, identifies methodological gaps, and outlines priorities for child-focused trial designs and longitudinal safety monitoring. Advances in neuronavigation, closed-loop stimulation, and artificial intelligence-guided dosing tailored to pediatric neurophysiology could transform epilepsy care by improving precision and individualization for children. rTMS is therefore best positioned as a promising adjunct for carefully selected pediatric patients, delivered within ethically approved, multidisciplinary research settings.
- 1 January 2025
- Published by King Salman Center for Disability Research in Journal of Disability Research
- Vol. 4 (6)
Open AccessRepetitive Transcranial Magnetic Stimulation for Pediatric Epilepsy: Current Evidence, Challenges, and Future Directions
Drug-resistant epilepsy affects 20-30% of children, where early and effective intervention is critical for reducing seizure frequency and neurodevelopmental outcomes, yet it remains a major therapeutic challenge. Pharmacotherapy often fails, and surgery or vagus nerve stimulation is not universally feasible. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a non-invasive neuromodulation strategy that modulates cortical excitability with magnetic pulses. In pediatric populations, rTMS may not only reduce seizure frequency and electrographic abnormalities but also support developmental domains, with adverse effects typically being mild and transient (e.g., scalp discomfort, headache). Beyond seizure reduction, reports describe improvements in cognition, behavior, and quality of life that are particularly relevant for children’s learning and psychosocial development. Mechanistically, rTMS likely acts through two complementary pathways: (i) desynchronization of abnormal cortical oscillations and (ii) modulation of synaptic efficacy via long-term potentiation and long-term depression like plasticity. TMS also has diagnostic and presurgical uses via motor-evoked potentials, paired-pulse paradigms, and TMS-electroencephalography biomarkers, providing clinicians with tools that can inform individualized treatment planning in young patients. However, evidence is heterogeneous, reflecting differences in age, epilepsy subtype, and stimulation parameters, alongside small sample sizes and protocol variability. Concerns specific to pediatrics including the long-term neurodevelopmental safety of repeated stimulation during critical brain maturation remain insufficiently characterized. Practical barriers such as access, cost, and clinician familiarity further limit adoption. This review synthesizes current pediatric rTMS evidence, identifies methodological gaps, and outlines priorities for child-focused trial designs and longitudinal safety monitoring. Advances in neuronavigation, closed-loop stimulation, and artificial intelligence-guided dosing tailored to pediatric neurophysiology could transform epilepsy care by improving precision and individualization for children. rTMS is therefore best positioned as a promising adjunct for carefully selected pediatric patients, delivered within ethically approved, multidisciplinary research settings.
- Open Access
- 1 January 2025
- Published by Green Publication
- Vol. 32 (5) , 854-864
THYROID FUNCTION CHANGES IN PEDIATRIC EPILEPSY PATIENTS: A PROSPECTIVE COMPARATIVE STUDY OF NEW VERSUS OLD ANTIEPILEPTIC DRUGS
Background: Epilepsy is a persistent neurological condition that requires prolonged treatment with antiepileptic drugs (AEDs). However, these medications can lead to other undesirable consequences, such as thyroid disorders. Aim: To evaluate the impact of old versus new antiepileptic medications on thyroid function in children with epilepsy. Methods: This prospective cohort study included epilepsy patients from the King Fahad Specialist Hospital in Dammam. Thyroid function tests (TSH, FT4, and FT3) were performed at baseline and one year after therapy. Statistical analysis included descriptive statistics, chi-square tests, independent-sample t-tests, and paired t-tests. Results: The study included 142 pediatric epilepsy patients (age range, 1–15 years), equally divided between new (50%) and old (50%) AED treatments. After one year of treatment, patients on newer AEDs showed significantly higher changes from a baseline in TSH (9.1764 vs. 4.0474 mIU/L, p = 0.001) and FT4 (11.5453 vs. 10.6243 pmol/L, p = 0.003) levels than those on older AEDs. Regardless of medication type, all patients experienced significant changes in all three crucial thyroid function indicators from baseline to one year post-treatment (p<0.001). TSH levels increased from 2.9726 to 6.5573 mIU/L, whereas FT4 and FT3 levels decreased (FT4: 11.8985 to 11.0783 pmol/L; FT3: 4.6999 to 4.2736 pmol/L). Furthermore, the New Medication Group has a significantly higher prevalence of Subclinical Hypothyroidism (66.2%) compared to the Old Medication Group (11.3%). The most common AEDs administered at baseline were sodium valproate (31.0%), levetiracetam (25.4%), carbamazepine (14.1%), and topiramate (12.7%). The medication groups had no significant differences regarding age, weight, height, and baseline thyroid function test results. Conclusion: New AEDs have a more significant influence on thyroid function in pediatric patients than old AEDs. Regular thyroid function monitoring is critical for all epilepsy patients undergoing long-term AED therapy, especially for those taking newer medicines. More studies are needed to understand better the underlying processes and long-term clinical consequences of medication-induced thyroid alterations.
- 1 January 2025
- Published by Green Publication
- Vol. 32 (5) , 854-864
Open AccessTHYROID FUNCTION CHANGES IN PEDIATRIC EPILEPSY PATIENTS: A PROSPECTIVE COMPARATIVE STUDY OF NEW VERSUS OLD ANTIEPILEPTIC DRUGS
Background: Epilepsy is a persistent neurological condition that requires prolonged treatment with antiepileptic drugs (AEDs). However, these medications can lead to other undesirable consequences, such as thyroid disorders. Aim: To evaluate the impact of old versus new antiepileptic medications on thyroid function in children with epilepsy. Methods: This prospective cohort study included epilepsy patients from the King Fahad Specialist Hospital in Dammam. Thyroid function tests (TSH, FT4, and FT3) were performed at baseline and one year after therapy. Statistical analysis included descriptive statistics, chi-square tests, independent-sample t-tests, and paired t-tests. Results: The study included 142 pediatric epilepsy patients (age range, 1–15 years), equally divided between new (50%) and old (50%) AED treatments. After one year of treatment, patients on newer AEDs showed significantly higher changes from a baseline in TSH (9.1764 vs. 4.0474 mIU/L, p = 0.001) and FT4 (11.5453 vs. 10.6243 pmol/L, p = 0.003) levels than those on older AEDs. Regardless of medication type, all patients experienced significant changes in all three crucial thyroid function indicators from baseline to one year post-treatment (p<0.001). TSH levels increased from 2.9726 to 6.5573 mIU/L, whereas FT4 and FT3 levels decreased (FT4: 11.8985 to 11.0783 pmol/L; FT3: 4.6999 to 4.2736 pmol/L). Furthermore, the New Medication Group has a significantly higher prevalence of Subclinical Hypothyroidism (66.2%) compared to the Old Medication Group (11.3%). The most common AEDs administered at baseline were sodium valproate (31.0%), levetiracetam (25.4%), carbamazepine (14.1%), and topiramate (12.7%). The medication groups had no significant differences regarding age, weight, height, and baseline thyroid function test results. Conclusion: New AEDs have a more significant influence on thyroid function in pediatric patients than old AEDs. Regular thyroid function monitoring is critical for all epilepsy patients undergoing long-term AED therapy, especially for those taking newer medicines. More studies are needed to understand better the underlying processes and long-term clinical consequences of medication-induced thyroid alterations.
- 9 November 2023
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (3) , 957-960
Navigated transcranial magnetic stimulation to measure motor evoked potentials in a child with hemispheric polymicrogyria and focal epilepsy
Malformations of cortical development such as polymicrogyria can cause medically refractory epilepsy. Epilepsy surgery (hemispherotomy) can be a good treatment option. In recent years, navigated transcranial magnetic stimulation (nTMS), a noninvasive brain mapping technique, has been used to localize the eloquent cortex for presurgical evaluation of patients with epilepsy. In the present case study, neurophysiological markers of the primary motor cortex (M1), including resting motor threshold (rMT), motor evoked potentials (MEPs), and silent period (SP), were assessed in both hands of a right-handed 10-year-old girl with a history of epilepsy and right hemispheric polymicrogyria. Bilateral MEPs with short latencies were elicited from the contralesional side. The average MEP amplitude and the latency for the patient’s paretic and non-paretic hands differed significantly. We conclude that nTMS is a safe and tolerable procedure that can be used for presurgical evaluation in children with intractable epilepsy.
- 9 November 2023
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (3) , 957-960
Navigated transcranial magnetic stimulation to measure motor evoked potentials in a child with hemispheric polymicrogyria and focal epilepsy
Malformations of cortical development such as polymicrogyria can cause medically refractory epilepsy. Epilepsy surgery (hemispherotomy) can be a good treatment option. In recent years, navigated transcranial magnetic stimulation (nTMS), a noninvasive brain mapping technique, has been used to localize the eloquent cortex for presurgical evaluation of patients with epilepsy. In the present case study, neurophysiological markers of the primary motor cortex (M1), including resting motor threshold (rMT), motor evoked potentials (MEPs), and silent period (SP), were assessed in both hands of a right-handed 10-year-old girl with a history of epilepsy and right hemispheric polymicrogyria. Bilateral MEPs with short latencies were elicited from the contralesional side. The average MEP amplitude and the latency for the patient’s paretic and non-paretic hands differed significantly. We conclude that nTMS is a safe and tolerable procedure that can be used for presurgical evaluation in children with intractable epilepsy.
- Open Access
- 1 October 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (4) , 451-463
Hemispherotomy for Epilepsy: The Procedure Evolution and Outcome
Hemispherectomy is a unique epilepsy surgery procedure that has undergone significant modification and evolution since Dandy’s early description. This procedure is mainly indicated to treat early childhood and infancy medically intractable epilepsy. Various epileptic syndromes have been treated with this procedure, including hemimegalencephaly (HME), Rasmussen’s encephalitis, Sturge–Weber syndrome (SWS), perinatal stroke, and hemispheric cortical dysplasia. In terms of seizure reduction, hemispherectomy remains one of the most successful epilepsy surgery procedures. The modification of this procedure over many years has resulted in lower mortality and morbidity rates. HME might increase morbidity and lower the success rate. Future studies should identify the predictors of outcomes based on the pathology and the type of hemispherectomy. Here, based on a literature review, we discuss the evolution of hemispherectomy techniques and their outcomes and complications.
- 1 October 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (4) , 451-463
Open AccessHemispherotomy for Epilepsy: The Procedure Evolution and Outcome
Hemispherectomy is a unique epilepsy surgery procedure that has undergone significant modification and evolution since Dandy’s early description. This procedure is mainly indicated to treat early childhood and infancy medically intractable epilepsy. Various epileptic syndromes have been treated with this procedure, including hemimegalencephaly (HME), Rasmussen’s encephalitis, Sturge–Weber syndrome (SWS), perinatal stroke, and hemispheric cortical dysplasia. In terms of seizure reduction, hemispherectomy remains one of the most successful epilepsy surgery procedures. The modification of this procedure over many years has resulted in lower mortality and morbidity rates. HME might increase morbidity and lower the success rate. Future studies should identify the predictors of outcomes based on the pathology and the type of hemispherectomy. Here, based on a literature review, we discuss the evolution of hemispherectomy techniques and their outcomes and complications.